News

EpiCept will receive approximately $2.65 million in net proceeds from the offering. Rodman & Renshaw, a subsidiary of Rodman & Renshaw Capital Group, acted as the exclusive placement

Escitalopram oxalate is indicated for depression and generalized anxiety disorders and is marketed under the brand name Lexapro. Based on product development results, the company is preparing to

The study, to be performed in collaboration with the US Centers for Disease Control and Prevention (CDC) Rabies program, is scheduled to begin soon. This study will expand

According to Oncure Medical, the acquisition expands the company’s national network of radiation oncology centers to 36 centers in three states. Deloitte Corporate Finance acted as exclusive financial

Under the agreement, Invitrogen will provide access to its extensive human and mouse gene libraries for use by Lentigen for the development of ready-to-use lentiviral particles that deliver

Woojin Lee, president and founder of Cambridge Endo, said: “With the ability to articulate, rotate and lock, our Autonomy Lapro-Angle instruments vastly improve the surgeon’s dexterity in tight

Serenity’s drug candidate will be delivered using Cpex’s patented drug delivery technology. Serenity believes the drug targets a potential worldwide market of $2-$3 billion. The collaboration between Serenity

Effective September 1, 2008, ProEthic will change name to Kowa Pharmaceuticals America and will assume responsibility for all sales and marketing functions currently operating in Montgomery, Alabama. ProEthic’s

For the development of this software, Clinilabs provided support to AMPS from clinical and core laboratory perspectives. The first installation of TrialPerfect was conducted at Clinilabs. The combination